MedTrace Logo

Effectiveness of the Individualized Metacognitive Training (EMC+) in People With Psychosis of Brief Evolution

NCT04429412 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2020-06-12

No results posted yet for this study

Summary

The main aim of the study is to evaluate the effectiveness of Individualized Meta-Cognitive Training (EMC +), in people with psychosis of brief evolution on symptoms, especially on positive symptoms. Secondary aims would be to assess the effect of EMC+ in metacognition, psychosocial and neuropsychological functioning, and to assess the maintenance of program effects on 6 months.

Conditions

  • Brief Psychotic Disorder
  • Psychosis; Episode

Interventions

BEHAVIORAL

MCT+

Metacognitive training

Sponsors & Collaborators

  • Parc Sanitari Sant Joan de Déu

    collaborator OTHER

  • Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz

    collaborator OTHER

  • Servicio Andaluz Jaén y Málaga

    collaborator UNKNOWN

  • Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

    collaborator OTHER

  • Parc de Salut Mar

    collaborator OTHER

  • Centre d'Higiene Mental Les Corts

    collaborator OTHER

  • Institut Pere Mata

    collaborator UNKNOWN

  • Institut Assistència Sanitària Girona

    collaborator UNKNOWN

  • Hospital Clínico Universitario de Valencia

    collaborator OTHER

  • Fundació Sant Joan de Déu

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-01
Primary Completion
2016-09-01
Completion
2018-09-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04429412 on ClinicalTrials.gov